Biosenic obtains a patent in China for the use of arsenic salts and metal ions – 08/24/2023 at 09:33

(AOF) – Biosenic announces that it has obtained a patent from the Chinese administration, covering the therapeutic use of arsenic salts and metal ions. This company specializing in clinical trials in serious autoimmune and inflammatory diseases and cell therapy, specifies that the Chinese National Administration of Intellectual Property (CNIPA), awarded it a patent entitled “Use…

Read More